Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

SELL
$24.89 - $43.41 $203,699 - $355,267
-8,184 Reduced 40.07%
12,240 $512,000
Q4 2022

Feb 13, 2023

SELL
$38.78 - $46.78 $407,190 - $491,190
-10,500 Reduced 33.95%
20,424 $848,000
Q3 2022

Nov 14, 2022

SELL
$30.9 - $50.65 $386,250 - $633,125
-12,500 Reduced 28.79%
30,924 $1.28 Million
Q2 2022

Nov 14, 2022

SELL
$29.23 - $44.45 $333,222 - $506,730
-11,400 Reduced 20.79%
43,424 $1.42 Million
Q2 2022

Sep 13, 2022

BUY
$29.23 - $44.45 $1.27 Million - $1.93 Million
43,424 New
43,424 $1.42 Million
Q2 2022

Aug 02, 2022

SELL
$29.23 - $44.45 $1.6 Million - $2.44 Million
-54,824 Closed
0 $0
Q1 2022

Nov 14, 2022

BUY
$16.89 - $35.74 $192,546 - $407,436
11,400 Added 26.25%
54,824 $1.92 Million
Q1 2022

Sep 13, 2022

BUY
$16.89 - $35.74 $925,977 - $1.96 Million
54,824 New
54,824 $1.92 Million

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $3.05B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Brown Advisory Inc Portfolio

Follow Brown Advisory Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Inc with notifications on news.